Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Acadia Healthcare Co's 10-Year RORE % for the quarter that ended in Jun. 2026 was 119.24%.
The industry rank for Acadia Healthcare Co's 10-Year RORE % or its related term are showing as below:
FRA:7RA's 10-Year RORE % is ranked better than 95.62% of 320
companies
in the Healthcare Providers & Services industry
Industry Median: 6.92
vs FRA:7RA: 119.24
Acadia Healthcare Co (FRA:7RA) 10-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Acadia Healthcare Co 10-Year RORE % Related Terms
Acadia Healthcare Co 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for Acadia Healthcare Co's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7RA vs OPCH, NHC, BKD: 10-Year RORE % Comparison
For the Medical Care Facilities subindustry, Acadia Healthcare Co's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acadia Healthcare Co 10-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acadia Healthcare Co's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where Acadia Healthcare Co's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2026 and 10-year before.
Acadia Healthcare Co (FRA:7RA) has a 10-Year RORE % of 119.24 as of Jun. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Acadia Healthcare Co and its competitors. According to the industry distribution chart, Acadia Healthcare Co ranks #14 out of 320 companies in the Healthcare Providers & Services industry, placing it in the top 4.4%.
Is Acadia Healthcare Co's 10-Year RORE % too high?
Acadia Healthcare Co's current 10-Year RORE % is 119.24. The Healthcare Providers & Services industry median 10-Year RORE % is 6.92. Acadia Healthcare Co's value of 119.24 is 1623.1% above this industry median. Based on the distribution chart, Acadia Healthcare Co ranks #14 out of 320 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Acadia Healthcare Co has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Acadia Healthcare Co's 10-Year RORE % compare to OPCH and NHC?
According to the Healthcare Providers & Services industry distribution chart, Acadia Healthcare Co ranks #14 out of 320 companies for 10-Year RORE %. This places Acadia Healthcare Co in the top 4% of its industry — outperforming the majority of peers. The industry median 10-Year RORE % is 6.92. Acadia Healthcare Co's value of 119.24 is 1623.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Healthcare Providers & Services company?
The median 10-Year RORE % among Healthcare Providers & Services companies is 6.92, based on 320 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acadia Healthcare Co's current 10-Year RORE % of 119.24 is 1623.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Acadia Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median 10-Year RORE % is 6.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acadia Healthcare Co's current 10-Year RORE % is 119.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acadia Healthcare Co stock overvalued right now?
Acadia Healthcare Co (FRA:7RA) has a current 10-Year RORE % of 119.24. The stock's GF Value™ is €34.17, compared to a current price of €25.40 — trading 25.7% below its estimated fair value. The current 10-Year RORE % is 119.24 and 1623.1% above the Healthcare Providers & Services industry median of 6.92. Acadia Healthcare Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Acadia Healthcare Co (FRA:7RA), the current 10-Year RORE % is 119.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acadia Healthcare Co (FRA:7RA) Overvalued in 2026?
Based on GuruFocus' analysis, Acadia Healthcare Co stock appears to be undervalued.
The current stock price of €25.40 is trading 25.7% below its estimated GF Value™ of €34.17.
Key valuation signals for FRA:7RA:
10-Year RORE %: 119.24
GF Value™: €34.17 vs. price of €25.40 (25.7% below fair value)
Industry Position: 1623.1% above the Healthcare Providers & Services median (#14 of 320)
No single metric tells the full story. See the FRA:7RA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
64GF Score
Get the complete analysis for FRA:7RA
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7RA has been successfully added to your 
